These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prion diseases of the central nervous system. Prusiner SB; DeArmond SJ Monogr Pathol; 1990; (32):86-122. PubMed ID: 2192281 [TBL] [Abstract][Full Text] [Related]
5. BSE: can we predict the future? Plum J Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370 [TBL] [Abstract][Full Text] [Related]
6. Prion protein self-interactions: a gateway to novel therapeutic strategies? Rigter A; Langeveld JP; van Zijderveld FG; Bossers A Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496 [TBL] [Abstract][Full Text] [Related]
7. [Biology of non-conventional transmissible agents or prions]. Dormont D Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035 [TBL] [Abstract][Full Text] [Related]
8. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Liemann S; Glockshuber R Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068 [TBL] [Abstract][Full Text] [Related]
9. Role of the 37 kDa laminin receptor precursor in the life cycle of prions. Rieger R; Lasmézas CI; Weiss S Transfus Clin Biol; 1999 Feb; 6(1):7-16. PubMed ID: 10188208 [TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of neuroinvasion by prions: molecular principles and present state of research]. Brandner S; Klein MA; Aguzzi A Schweiz Med Wochenschr; 2000 Mar; 130(12):435-42. PubMed ID: 10780058 [TBL] [Abstract][Full Text] [Related]
13. The state of the prion. Weissmann C Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743 [TBL] [Abstract][Full Text] [Related]
14. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry. Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021 [TBL] [Abstract][Full Text] [Related]
15. [Transmissible spongiform encephalopathies (prion diseases)--molecular principles and in vitro models]. Kretzschmar H Wien Med Wochenschr; 1998; 148(4):67-73. PubMed ID: 9611345 [TBL] [Abstract][Full Text] [Related]
16. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy. Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798 [TBL] [Abstract][Full Text] [Related]
17. Prion agent diversity and species barrier. Béringue V; Vilotte JL; Laude H Vet Res; 2008; 39(4):47. PubMed ID: 18519020 [TBL] [Abstract][Full Text] [Related]
18. Molecular clues to pathogenesis in prion diseases. Laurent M; Johannin G Histol Histopathol; 1997 Apr; 12(2):583-94. PubMed ID: 9151145 [TBL] [Abstract][Full Text] [Related]
19. Transgenetic investigations of prion diseases of humans and animals. Prusiner SB Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):239-54. PubMed ID: 8097053 [TBL] [Abstract][Full Text] [Related]
20. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Vilette D; Andreoletti O; Archer F; Madelaine MF; Vilotte JL; Lehmann S; Laude H Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4055-9. PubMed ID: 11259656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]